New advanced technology-enabled offering aims to streamline synthetic route identification for novel active pharmaceutical ingredients (APIs)
One form of thalidomide has the intended sedative effect but the opposite mirror-image form interferes with foetal development
The partners will collaborate to build a cutting-edge oligonucleotide cGMP manufacturing facility
Aurigene.AI is an end-to-end solution for small molecule drug discovery
The facility will manufacture Specialty and Fine Chemicals tailored to various applications across industries such as Polymer and Water Treatment facilities
With this, the total number of Patents granted to company for its innovative processes and technology stands at 9
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery
GMP certification helps enable biotechnology customers to accelerate accessibility of new RNA-based therapies for patients
SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates
Astellas has acquired abiraterone decanoate being developed by Propella to treat prostate cancer
Subscribe To Our Newsletter & Stay Updated
